KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Prepaid Assets: 2009-2025

Historic Prepaid Assets for Rigel Pharmaceuticals (RIGL) over the last 16 years, with Sep 2025 value amounting to $18.6 million.

  • Rigel Pharmaceuticals' Prepaid Assets rose 85.67% to $18.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.6 million, marking a year-over-year increase of 85.67%. This contributed to the annual value of $10.2 million for FY2024, which is 62.35% up from last year.
  • Rigel Pharmaceuticals' Prepaid Assets amounted to $18.6 million in Q3 2025, which was up 11.22% from $16.7 million recorded in Q2 2025.
  • Over the past 5 years, Rigel Pharmaceuticals' Prepaid Assets peaked at $23.3 million during Q1 2025, and registered a low of $3.0 million during Q3 2023.
  • In the last 3 years, Rigel Pharmaceuticals' Prepaid Assets had a median value of $8.8 million in 2024 and averaged $10.8 million.
  • Per our database at Business Quant, Rigel Pharmaceuticals' Prepaid Assets crashed by 51.03% in 2023 and then soared by 231.48% in 2024.
  • Quarterly analysis of 5 years shows Rigel Pharmaceuticals' Prepaid Assets stood at $7.4 million in 2021, then rose by 11.43% to $8.3 million in 2022, then declined by 24.19% to $6.3 million in 2023, then spiked by 62.35% to $10.2 million in 2024, then surged by 85.67% to $18.6 million in 2025.
  • Its last three reported values are $18.6 million in Q3 2025, $16.7 million for Q2 2025, and $23.3 million during Q1 2025.